All data are based on the daily closing price as of July 18, 2024
h

Hyundai Bioscience

048410.KQ
12.93 USD
-0.02
-0.15%

Overview

Last close
12.93 usd
Market cap
514.95M usd
52 week high
30.24 usd
52 week low
12.69 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
83.4635
Price/Book Value
17.4802
Enterprise Value
515.24M usd
EV/Revenue
82.8026
EV/EBITDA
-61.5809

Key financials

Revenue TTM
8.22M usd
Gross Profit TTM
2.45M usd
EBITDA TTM
-3.72M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
39.91M usd
Net debt
N/A usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.
  • Symbol
    048410.KQ
  • Exchange
    KQ
  • Isin
    KR7048410005
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Biotechnology
  • CEO
    Jong-Won Choi
  • Headquarter
    Seoul
  • Web site
    https://www.hyundaibioscience.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top